We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA hit a Rockledge, Florida over-the-counter drugmaker with a warning letter over failures related to testing, quality unit oversight and water quality monitoring. Read More
A bipartisan drug pricing bill currently awaiting a vote on the Senate floor could have unintended consequences for generics, according to the Association for Accessible Medicines. Read More
Bristol-Myers Squibb and Sanofi have filed a complaint against the state of Hawaii over a lawsuit that seeks massive fines against the drugmakers for failing to include a warning in labeling for their anti-blood clotting drug Plavix (clopidogrel). Read More
The EMA authorized fewer new active substances and orphan drugs in 2019 than in the previous year, according to the agency’s highlights released yesterday. Read More
Hospira prevailed this week in a Florida lawsuit that alleged the Pfizer subsidiary falsely advertised its epinephrine products as being FDA approved. Read More
In an unusual move, Celgene has backed out of a $55 million settlement to clear accusations of anticompetitive behavior over its cancer treatments Revlimid and Thalomid, attorneys for the plaintiffs announced Wednesday. Read More